Larimar Therapeutics
LRMR
LRMR
85 hedge funds and large institutions have $78.5M invested in Larimar Therapeutics in 2019 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
43% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 21
49% less capital invested
Capital invested by funds: $153M → $78.5M (-$74.7M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $100K
Holders
85
Holding in Top 10
2
Calls
–
Puts
$100K
Top Buyers
| 1 | +$2.33M | |
| 2 | +$1.29M | |
| 3 | +$712K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$604K |
| 5 |
Renaissance Technologies
New York
|
+$559K |
Top Sellers
| 1 | -$3.71M | |
| 2 | -$2.71M | |
| 3 | -$2.59M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.26M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.17M |